Home › Stocks › PTCT › All Fund Holders
PTCT — PTC THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 46 · Reported value held: $3.98B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 13.96M | $1.14B | 0.02% | Add |
| Vanguard Group history | Q4 2025 | 8.80M | $668.69M | 0.01% | Add |
| Janus Henderson Group history | Q1 2026 | 7.19M | $490.00M | 0.24% | Add |
| Wellington Management Group history | Q2 2026 | 4.13M | $336.74M | 0.06% | Add |
| Geode Capital Management history | Q2 2026 | 2.21M | $180.09M | 0.01% | Hold |
| D. E. Shaw & Co history | Q2 2026 | 1.55M | $126.35M | 0.07% | Reduce |
| Bank of America Corp history | Q2 2026 | 1.45M | $118.46M | 0.01% | Reduce |
| Point72 Asset Management history | Q4 2025 | 1.13M | $85.72M | 0.10% | Reduce |
| Franklin Resources history | Q2 2026 | 1.03M | $83.80M | 0.02% | Reduce |
| Invesco Ltd history | Q2 2026 | 941.58K | $76.80M | 0.01% | Add |
| Northern Trust Corp history | Q2 2026 | 880.03K | $71.78M | 0.01% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 790.11K | $64.45M | 0.01% | Add |
| Renaissance Technologies history | Q2 2026 | 723.50K | $59.02M | 0.08% | Add |
| Marshall Wace history | Q2 2026 | 704.79K | $57.49M | 0.05% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 684.04K | $56.07M | 0.01% | New |
| Arrowstreet Capital history | Q2 2026 | 654.38K | $53.38M | 0.02% | Add |
| Goldman Sachs Group history | Q2 2026 | 618.25K | $50.43M | 0.01% | Reduce |
| Principal Global Investors history | Q2 2026 | 541.63K | $44.18M | 0.02% | Add |
| Manulife Financial history | Q2 2026 | 441.96K | $36.05M | 0.03% | Add |
| Legal & General Investment Management America history | Q2 2026 | 352.73K | $28.77M | 0.01% | Add |
| AQR Capital Management history | Q2 2026 | 332.25K | $27.10M | 0.01% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 296.90K | $24.22M | 0.01% | Add |
| PSP Investments history | Q2 2026 | 285.02K | $23.25M | 0.06% | Reduce |
| UBS Group AG history | Q2 2026 | 262.43K | $21.41M | 0.01% | Reduce |
| Prudential Financial history | Q2 2026 | 185.82K | $15.16M | 0.02% | Add |
| Citigroup Inc history | Q2 2026 | 118.66K | $9.68M | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 83.07K | $6.78M | 0.00% | Add |
| Moore Capital Management history | Q2 2026 | 75.59K | $6.17M | 0.10% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 2.99M | $4.72M | 0.00% | Hold |
| Norges Bank Investment Management history | Q4 2025 | 53.81K | $4.09M | 0.00% | New |
| Millennium Management history | Q2 2026 | 46.49K | $3.79M | 0.00% | New |
| Polen Capital Management history | Q2 2026 | 24.92K | $2.03M | 0.02% | New |
| Balyasny Asset Management history | Q2 2026 | 20.61K | $1.68M | 0.00% | Reduce |
| Bridgewater Associates history | Q4 2025 | 16.23K | $1.23M | 0.00% | Add |
| Amundi US history | Q2 2026 | 12.23K | $997.36K | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 10.65K | $869.05K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 10.58K | $862.85K | 0.00% | Add |
| Royce & Associates history | Q2 2026 | 9.52K | $776.79K | 0.01% | Reduce |
| MFS Investment Management history | Q2 2026 | 7.28K | $594.07K | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 6.50K | $530.21K | 0.00% | Reduce |
| CPP Investments history | Q2 2026 | 5.40K | $440.48K | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 200.00K | $326.45K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 1.11M | $90.91K | 0.01% | Add |
| Morgan Stanley history | Q2 2026 | 53.00K | $83.74K | 0.00% | Reduce |
| Lazard Asset Management history | Q2 2026 | 2.19M | $34.68K | 0.00% | Reduce |
| Baillie Gifford & Co history | Q1 2023 | 278 | $13.47K | 0.00% | Add |